A survey commissioned by Public Health England (PHE) has found that around nine in ten people support the government working with the food industry to make food healthier.
20th November 2018
A late-stage study testing Merck KGaA and Pfizer’s PD-L1 antibody Bavencio has failed to meet its primary endpoints in patients with certain forms of ovarian cancer.
20th November 2018
Cardiff University has formed a drug discovery collaboration with Takeda to identify new approaches for treating schizophrenia and other psychiatric disorders.
20th November 2018
US regulators have expanded the scope of Novartis’ Promacta to include earlier use of the drug to treat adults and paediatric patients with severe aplastic anaemia (SAA) in combination with standard immunosuppressive therapy (IST).
19th November 2018
AstraZeneca’s Imfinzi has failed to show a significant benefit over standard of care (SoC) chemotherapy on overall survival in certain patients with lung cancer.
19th November 2018
NICE has given a green light for use of MSD’s Keytruda on the NHS to treat some patients with melanoma, with funding to come from the Cancer Drugs Fund.
19th November 2018
Four medicines have taken a giant leap closer to approval having won the backing of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).
19th November 2018
The annual PharmaTimes Marketer of the Year and Communications Team of the Year awards ceremonies took place last night at the Tower Hotel London, with a special addition for this year – the PharmaTimes Sales Awards.
16th November 2018
The Brexit Health Alliance (BHA) has welcomed the agreement on the terms of the UK’s withdrawal from the European Union (EU).
16th November 2018
UK drug discovery and development group Mission Therapeutics has signed a deal with AbbVie focusing on early stage development of specified DUB inhibitors for the treatment of Alzheimer’s Disease and Parkinson’s Disease.
16th November 2018
Shire says it presented data showing that its experimental drug lanadelumab provides a significant and clinically meaningful reduction of hereditary angioedema (HAE) attacks.
16th November 2018
NICE has recommended a pioneering cancer treatment for people under the age of 25 with leukaemia in final draft guidelines.
16th November 2018
MSD’s Keytruda has shown promise in a late-stage trial testing its safety and efficacy in patients with advanced or metastatic esophageal or esophagogastric junction carcinoma.
15th November 2018
Cost regulators for the NHS in England and Wales have now published final guidelines recommending Mylotarg, alongside daunorubicin and cytarabine, as an option for untreated de novo CD33-positive acute myeloid leukaemia (AML).
15th November 2018
The National Institute for Health Research is streaming £5 million of global health funding into research looking at how infectious diseases spread and develop into epidemics in low- and middle-income countries.
15th November 2018
